Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
1.735
+0.015 (0.87%)
Dec 19, 2025, 2:47 PM EST - Market open
Neumora Therapeutics Market Cap
Neumora Therapeutics has a market cap or net worth of $294.84 million as of December 19, 2025. Its market cap has decreased by -81.13% in one year.
Market Cap
294.84M
Enterprise Value
145.95M
1-Year Change
-81.13%
Ranking
Category
Stock Price
$1.74
Market Cap Chart
Since the IPO on September 15, 2023, Neumora Therapeutics's market cap has decreased from $2.58B to $294.84M, a decrease of -88.59%. That is a compound annual growth rate of -61.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 18, 2025 | 292.29M | -82.93% |
| Dec 31, 2024 | 1.71B | -34.22% |
| Dec 29, 2023 | 2.60B | 0.79% |
| Sep 15, 2023 | 2.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 932.80B |
| Johnson & Johnson | 506.75B |
| AbbVie | 396.44B |
| UnitedHealth Group | 300.40B |
| AstraZeneca | 281.50B |
| Novartis AG | 260.63B |
| Merck & Co. | 246.17B |
| Abbott Laboratories | 220.33B |